Trial Profile
To compare the smoking cessation efficacy and safety of e-cigarettes (EC) with varenicline among patients who continue to smoke after a acute coronary syndromes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 18 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology